Gentamicin effects on renal ischemia/reperfusion injury

Area of Science:

• Nephrology
• Pharmacology
• Cellular Biology

Background:

• Aminoglycosides like gentamicin are crucial antibiotics but can cause kidney damage.
• The precise mechanisms by which gentamicin affects ischemia/reperfusion (I/R) renal injury remain unclear.
• Understanding gentamicin's role in postischemic acute renal failure is vital for patient safety.

Purpose of the Study:

• To investigate how gentamicin administration timing influences ischemia/reperfusion renal injury.
• To elucidate the cellular mechanisms underlying gentamicin's effect on postischemic kidneys.
• To determine if antioxidants can protect against gentamicin-induced exacerbation of I/R injury.

Main Methods:

• Rats underwent renal pedicle occlusion (25 minutes) with varying gentamicin treatment timings (preischemic or postischemic).
• Isolated rat proximal tubular segments were exposed to hypoxia/reoxygenation with or without gentamicin.
• Cellular energetics (ATP/ADP ratios), morphological damage, and gentamicin accumulation were assessed.

Main Results:

• Both preischemic and postischemic gentamicin treatments equally worsened acute renal failure.
• Gentamicin reduced hypoxic damage in isolated tubules but impaired cellular energetics (ATP/ADP) during reperfusion.
• Antioxidants did not protect against gentamicin's adverse effects on I/R injury; gentamicin accumulated more in postischemic kidneys.

Conclusions:

• Gentamicin exacerbates postischemic acute renal failure primarily by affecting the reperfusion phase, not ischemic injury.
• Impaired cellular energetics due to increased gentamicin accumulation in reperfused kidneys likely drives the exacerbation.
• Timing of gentamicin administration does not alter its detrimental impact on I/R renal injury severity.